"The stigma, fear and ignorance associated with HIV are still very strong; those of us who do this work on a daily basis might forget this sad fact," Paul Sax, M.D., writes.
"Nationally, we've seen only modest progress in retaining people in HIV care. The amount of improvement hasn't been enough."
Leading microbicide advocate Jim Pickett calls for the head of NIAID to persuade Division of AIDS chief Carl Diffenbach to "consider microbicides with the same passion and intensity and commitment he has for vaccines and long-acting formulations."...
With black women at far greater risk for HIV than women of any other race or ethnicity, health organizations should think more creatively about how to bring them HIV and PrEP information.
"As health care professionals, we can help long-term survivors embrace a life they never expected to live with a conscious awareness and acknowledgment of their life experience," writes David Fawcett Ph.D., L.C.S.W.
A new report documents 2016 funding and highlights a continuing trend of flat or declining funding and its potential impact on further innovation in HIV prevention research and development.
It's time that patients, providers, pharmaceutical companies and the public health community have honest and difficult conversations about condoms, PrEP and bodily pleasure.
"There are a few reasons not to answer questions from clinicians you've never met about patients you haven't seen," writes Paul Sax, M.D.